Drug therapy for atrial fibrillation: quo vadis?
Atrial fibrillation has always been the most common sustained cardiac arrhythmia, and its incidence is increasing worldwide. Despite evolving ablation techniques, the vastness of the number of cases entrenches drug therapy as the mainstay of treatment for the majority of cases both now and in the fo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South African Heart Association
2017-04-01
|
| Series: | SA Heart Journal |
| Subjects: | |
| Online Access: | https://www.journals.ac.za/index.php/SAHJ/article/view/2017 |